D.A. Davidson & CO. Sells 38,478 Shares of CVS Health Co. (NYSE:CVS)

D.A. Davidson & CO. decreased its position in shares of CVS Health Co. (NYSE:CVS - Free Report) by 15.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 202,933 shares of the pharmacy operator's stock after selling 38,478 shares during the period. D.A. Davidson & CO.'s holdings in CVS Health were worth $12,760,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of CVS. MidAtlantic Capital Management Inc. bought a new position in CVS Health during the 3rd quarter worth $25,000. Livelsberger Financial Advisory acquired a new stake in shares of CVS Health during the 3rd quarter worth $31,000. Reston Wealth Management LLC bought a new position in shares of CVS Health in the third quarter worth $32,000. First Community Trust NA raised its stake in CVS Health by 116.2% in the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator's stock valued at $33,000 after purchasing an additional 302 shares in the last quarter. Finally, Kathleen S. Wright Associates Inc. bought a new stake in CVS Health during the third quarter worth about $33,000. Institutional investors and hedge funds own 80.66% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on CVS. Mizuho lowered their price target on CVS Health from $73.00 to $66.00 and set an "outperform" rating for the company in a report on Thursday, October 24th. StockNews.com downgraded CVS Health from a "hold" rating to a "sell" rating in a research note on Thursday, November 14th. Evercore ISI lifted their price target on shares of CVS Health from $62.00 to $75.00 and gave the company an "outperform" rating in a report on Tuesday, October 8th. Wells Fargo & Company upgraded shares of CVS Health from an "equal weight" rating to an "overweight" rating and raised their target price for the company from $60.00 to $66.00 in a research report on Monday, November 18th. Finally, Barclays lowered their price target on shares of CVS Health from $75.00 to $71.00 and set an "overweight" rating for the company in a report on Thursday, November 7th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and thirteen have assigned a buy rating to the company's stock. According to MarketBeat, CVS Health presently has a consensus rating of "Moderate Buy" and an average target price of $70.33.

CVS Health Trading Up 1.6 %

CVS Health stock traded up $0.95 during mid-day trading on Wednesday, hitting $59.96. 7,596,294 shares of the stock were exchanged, compared to its average volume of 11,346,436. The firm's fifty day simple moving average is $59.30 and its two-hundred day simple moving average is $58.72. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. CVS Health Co. has a 12 month low of $52.71 and a 12 month high of $83.25. The stock has a market capitalization of $75.45 billion, a price-to-earnings ratio of 15.22, a PEG ratio of 1.01 and a beta of 0.55.

CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, beating analysts' consensus estimates of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The business had revenue of $95.43 billion for the quarter, compared to analysts' expectations of $92.72 billion. During the same quarter in the prior year, the firm posted $2.21 earnings per share. The business's quarterly revenue was up 6.3% compared to the same quarter last year. Analysts forecast that CVS Health Co. will post 5.43 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, November 1st. Shareholders of record on Monday, October 21st were paid a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 4.44%. The ex-dividend date was Monday, October 21st. CVS Health's dividend payout ratio (DPR) is presently 67.51%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.